William M. Janssen
Professor of Law
Articles
Some Appeal-Endangering Nuances of the Federal ‘Separate-Document’ Rule, 2024 FDLI Update 26 (June 2024). Available at https://www.fdli.org/resources/update-magazine/
It's Elementary. Let's Play Rock, Paper, Scissors: Civil Procedure, Property, Contracts, and Torts During First-Year Law School Orientation (with Aleatra P. Alexander, Constance A. Anastopoulo, & Jean Steadman), 54 MEMPHIS L. REV. 513, book 3, (2024).
Inadvertent Dishonesty, 85 Pitt. L. Rev. 659 (2024). https://doi.org/10.5195/lawreview.2024.1018.
Twombly and Affirmative Defenses: Where Things Stand, Fed. Law. (2023). Available at https://issuu.com/federalbarassociation/docs/tfl_fall2023_final
Rule 4(d) and Self-Initiated Extensions to Answer, 68 Fed. Law. 54 (2021). Available at [Hein].
A Land Mine in Rule 12(c) Motions for Judgment on the Pleadings, 67 Fed. Law. 64 (2020). Available at https://issuu.com/federalbarassociation/docs/tfl_nov-dec2020
Un-"Stacking" Class Actions, 2018 FDLI Update 20 (2018). Available at https://www.fdli.org/2018/11/un-stacking-class-actions/
Remands by Deception, 81 Mo. L. Rev. 75 (2016). Available at https://scholarship.law.missouri.edu/mlr/vol81/iss1/18/
South Carolina's Mysterious Sometimes-Disappearing Long-Arm Statute: The Confounding Conflation Conundrum, 27 S.C. Law. 38 (2016). Available at [Hein].
A Duty to Continue Selling Medicines, 40 AM. J.L. & Med. 330 (2014). Available at [Hein].
The Odd State of Twiqbal Plausibility in Pleading Affirmative Defenses, 70 Wash. & Lee L. Rev. 1573 (2013). Available at https://scholarlycommons.law.wlu.edu/wlulr/vol70/iss3/4/
Toiling in the Lemon Groves: Prelude to the Endorsement Test, 7 Charleston L. Rev. 691 (2013). Available at [Hein].
Led Blindly: One Circuit's Struggle to Faithfully Apply the U.S. Supreme Court's Religious Symbols Constitutional Analysis, 116 W. Va. L. Rev. 33 (2013). Available at https://researchrepository.wvu.edu/wvlr/vol116/iss1/5/
Hon. Joseph F. Weis, Jr.: Senior Circuit Judge, U.S. Court of Appeals for the Third Circuit, 59 Fed. Law. 23 (2012). Available at https://www.fedbar.org/wp-content/uploads/2019/10/WeisOctNov2012-pdf-3.pdf
Iqbal Plausibility in Pharmaceutical and Medical Device Litigation, 71 La. L. Rev. 541 (2011). Available at https://digitalcommons.law.lsu.edu/lalrev/vol71/iss2/5/
Plotting a Teacher's Journey: From Courtroom to Classrooms, 2011 FDLI Update (2011).
Ethnic/Race Niche Drugs: Navigating Ethnicity and Race in Pharmaceuticals, 2006 FDLI Update 9 (2006). Available at [Hein].
Postmarketing Requirements for Medical Devices, 2005 FDLI Update 33 (2005). Available at [Hein].
FDA's Independent Drug Safety Board: The Quest To Restore Confidence in FDA's Stamp of Approval, Pharmaceutical Law Reporter, June 2005.
Your Business in Court, 2005 FDLI Update 4 (2005). Available at [Hein].
Group Justice? Legal Moves That Lump Pharma Cases Together Are Bad For Justice And Bad For The Industry, Pharmaceutical Executive (Dec. 2004). https://www.pharmexec.com/journals/pharmaceutical-executive/pharmaceutical-executive-12-01-2004
Books
Federal Civil Rules Handbook (31st ed.) (Thomas Reuters 2024).
Federal Practice & Procedure - CIVIL RULES: Quick Reference Guide Vol. 12B (Thomas Reuters 2023).
A Student's Guide to the Federal Rules of Civil Procedure (25th ed.) (West Academic Press 2023).
Mastering Multiple Choice for Federal Civil Procedure: MBE Bar Prep & 1L Exam Prep (4th ed.) (West Academic Press 2022).
Federal Civil Procedure Logic Maps (3rd ed.) (West Academic Press 2022).
Practicing Civil Discovery (Carolina Academic Press 2020).
Contributions to Books
Davis v. Disability Rights New Jersey, Printed in Top Food & Drug Cases 2023, & Cases to Watch, 2024, August T. Horvath, ed., Food & Drug Law Institute (May 2024).
Various, Printed in Rice's Attorney-Client Privilege in the United States, Paul Rice, ed., Lawyers Cooperative Publishing (2020).
In re: Mirena IUS Levonorgestrel-Related Products Liability Litigation (No. II), 387 F. Supp. 3d 323 (S.D.N.Y. 2019) [hereinafter IIH MDL Summary Judgment], Ford Motor Co. v. Bandemer, No. 19-369 (U.S.), on appeal from Bandemer v. Ford Motor Co., 931 N.W.2d 744 (Minn. July 31, 2019) and Polansky v. Executive Health Resources, Inc., No. 19-3810 (3d Cir.), on appeal from 422 F. Supp. 3d 916 (E.D. Pa. Nov. 5, 2019). Printed in Top Food and Drug Cases, 2019, & Cases to Watch, 2020, August T. Horvath, ed., Food & Drug Law Institute (2020).
Weddle v. Bayer AG Corporation, Printed in Top 20 Food and Drug Cases, 2012 & Cases to Watch, 2013, john B. Reiss & Gregory J. Wartman, ed., Food & Drug Law Institute (2013). Hein: https://heinonline.org/HOL/P?h=hein.journals/fdliup2013&i=166
Goodyear Dunlop Tires Operations, S.A. v. Brown, Printed in Top 20 Food and Drug Cases, 2011 & Cases to Watch, 2012, John B. Reiss & Gregory J. Wartman, ed., Food & Drug Law Institute (2012).https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2519226
Siracusano v. Matrixx Initiative, Inc, Printed in Top 20 Food and Drug Cases, 2010 & Cases to Watch, 2011, John B. Reiss, ed., Food & Drug Law Institute (2011).
Ashcroft v. Iqbal, Printed in Top 20 Food and Drug Cases, 2009 & Cases to Watch, 2010, John B. Reiss, ed., Food & Drug Law Institute (2010).
A Historical Perspective on Off-Label Medicine: From Regulation, Promotion, and the First Amendment to the Next Frontiers, Printed in Off-Label Communications, Mark C. Levy, ed., Food & Drug Law Institute (2008). https://papers.ssrn.com/sol3/papers.cfm?abstract_id=2519223
Medicine Meets Madison Avenue: The Direct-to-Consumer Advertising of Prescription Drugs, Printed in Promotion of Biomedical Products, Thomas E. Colonna & Jeffrey K. Shapiro, ed., Food & Drug Law Institute (2005), chapter 5. https://search.worldcat.org/title/70287220?oclcNum=70287220.
Selecting the Jury, Printed in Defense Counsel Training Manual, International Association of Defense Counsel (1995). https://search.worldcat.org/title/Defense-counsel-training-manual/oclc/32372792
Presentations
Jan. 2024. Panel Moderator and Lead Q&A. Religious Liberty in a Polarized Age. Charleston School of Law, CSOL Presentation.
Mar. 2023. Organizing Committee, Panel Introduction, and Panel Moderator. Irrepressible Civility, Professionalism, and Ethics in Defining the Lawyering Career. University of Pittsburgh Law Review - Symposium: The Jurisprudence of the Hon. Joseph F. Weis, Jr., Academic Conference & CLE.
Apr. 2023. Podcast. The Human Lawyer - Podcast on Lawyering and Teaching Professions.
May 2023. Presenter. Product Placement and Liability - Creating Representation. Food & Drug Institute - Annual Meeting, Academic Conference & CLE Program.
Sep. 2023. Presenter. What's New in Federal Civil Procedure. South Carolina Bar - Mastering Rules of Procedure and Evidence: Essential Strategies for South Carolina Attorneys, CLE Program.
Oct. 2023. Presenter. Applying Rule of Procedure to Formal Proceedings. South Carolina Probate Judges - Annual Conference, Judicial Training Program.
Oct. 2023. Presenter. Ethics from Practitioner's Perspective. CSOL - Professionalism Series, CSOL Presentation.
Sept. 29, 2023. Presenter. Mastering Rules of Procedure & Evidence: Essential Strategies for S.C. Attorneys: What's New in Federal Civil Practice, South Carolina Bar Continuing Legal Education Division.
Oct. 2018. Presenter. "Hidden" Rules: 15 Features Civil Practice You Might Not Have Yet Discovered, South Carolina Bar Continuing Legal Education.
April 25, 2012. Presenter. Personal Jurisdiction after Goodyear and McIntyre, Food & Drug Law Institute Annual Meeting.
April 6, 2011. Presenter. Matrixx Initiatives v. Siracusano - The Supreme Court Tackles the Meaning of ADEs in Pharmaceutical Securities Litigation, Food & Drug Law Institute Annual Meeting.
Sept.17, 2011. Presenter. A Decade of Federal Civil Rules Upheaval: A Path Worth Emulating or Avoiding?, Southern High Court Conference.
April 22, 2010. Presenter. Ashcroft v. Iqbal and Pleading in Federal Drug and Device Cases, Food & Drug Law Institute Annual Meeting.
May 2005. Presenter. Post-Marketing Requirements, Food and Drug Law Institute’s “Introduction To Medical Device Law And Regulation: Understanding How FDA Regulates The Medical Device Industry."
Other
Jurisprudence:
Citing: The Odd State of Twiqbal Plausibility in Pleading Affirmative Defenses, 70 WASH. & LEE L. REV. 1573 (2013).
Martin v. Trott Law, P.C., 265 F. Supp. 3d 731 (E.D. Mich. 2017).
NEWNET Comm. Tech. v. VI E-CELL Tropical TELECOM, 85 F. Supp. 3d 988 (N.D. Ill. 2015).
Vary v. City of Cleveland, 206 F. Supp. 3d 1273 (N.D. Ohio 2016).
Certain Underwriters at Lloyd's Subscribing to Policy No. TCN034699 v. Bell, Civil Action No. 5: 13-cv-113-DCB-MTP (S.D. Miss. Sept. 10, 2014).
Jam Tire, Inc. v. Harbin, No. 3: 14-cv-00489 (N.D. Ohio Sept. 5, 2014).
Federal Trade Commission v. Stratford Career Institute, No. 16-CV-371 (N.D. Ohio July 15, 2016).
Citing: A Duty to Continue Selling Medicines, 40 AM. J.L. & MED. 330 (2014).
Hochendoner v. Genzyme Corp., 95 F. Supp. 3d 15 (D. Mass. 2015).
Charleston School of Law podcast, Bill Janssen, Episode 8, May 2022.
